• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Digital medicine

Report: Virtual Care Still in ‘Wild West’ Days Sparking Confusion, High Optimism, Investment

by Syed Hamza Sohail 11/03/2022 Leave a Comment

Report: Virtual Care Still in ‘Wild West’ Days Sparking Confusion, High Optimism, Investment

What You Should Know: - A new "State of Virtual Care" report by Omada Health and Digital Medicine Society, in collaboration with Rock Health, reveals that buyers today are inundated with vendors labeling themselves “virtual care providers,” regardless of the care model they’re selling. This phenomenon is blurring their perception of V1C’s potential impact, and what that means for improvements in healthcare delivery and outcomes. - V1C solutions like Omada Health are changing the market,
Read More

Intel Invests $20M in Biofourmis’ Virtual Care Offerings

by Syed Hamza Sohail 08/10/2022 Leave a Comment

Biofourmis AI Analytics Engine Receives FDA Clearance for Ambulatory Physiologic Monitoring

What You Should Know: - Biofourmis, a Boston-based global leader in virtual care and digital medicine, today announced that Intel Capital, the strategic investment arm of chipmaker Intel Corporation, has joined its Series D financing in an extension that brings the total funding raised in the round to $320M. - The initial Series D funding round was announced in April and was led by global growth equity firm General Atlantic with participation by CVS Health (NYSE:CVS), Trevor
Read More

When It Comes to Digital Health, Experience Is Everything

by Aniket Singh Rajput, Founder and CEO of Neuroglee 06/27/2022 Leave a Comment

When It Comes to Digital Health, Experience Is Everything

Thanks to COVID-19 and numerous other factors, the adoption of digital health technologies used by patients in the home has skyrocketed. Accenture reported in 2021, for example, that remote patient monitoring technology adoption tripled among patients. Whether it is streaming video telehealth appointments with a provider, a remote patient monitoring platform, or a prescribed digital therapeutic to manage a chronic condition, the emphasis must be on the patient and caregiver
Read More

Delivering Patient-Centered Care Means Decluttering the Digital Health Landscape

by Simon Mathews, MD, Chief Medical Officer, Pager 05/17/2022 Leave a Comment

Delivering Patient-Centered Care Means Decluttering the Digital Landscape

Digital health companies (DHCs) and their solutions continue to grow at a rapid pace. This is in part being fueled by the record funding for DHCs, with over $29 billion for US-based companies in 2021 alone. As a result, patients are inundated with solutions from every direction – from employers, health plans, and directly through consumer-oriented apps and wearables. Physicians are also getting into the mix by directly prescribing digital therapeutics. On the surface, the blossoming of the
Read More

Biofourmis Secures $300M to Expand Virtual Care Offerings

by Digital Health Funding 04/26/2022 Leave a Comment

Biofourmis Secures $300M to Expand Virtual Care Offerings

What You Should Know: - Biofourmis, a global leader in virtual care and digital medicine raises $300 million in Series D investment led by leading global growth equity firm General Atlantic. CVS Health and existing investors also participated in the round, - Biofourmis also announced that former Medtronic CEO and Chairperson at Intel, Dr. Omar Ishrak, will join the company’s Board of Directors as Chairman. Transforming Patient Health Through Personalized, Predictive Care Founded in
Read More

physIQ, CellCarta Collaborate on Study to Revolutionize Vaccine

by Jasmine Pennic 03/17/2022 Leave a Comment

physIQ, CellCarta Collaborate on Study to Revolutionize Vaccine

What You Should Know: - Today, digital medicine leader physIQ and CellCarta, a global leader in precision medicine services announced they are collaborating on a groundbreaking study that could revolutionize vaccine development. - The strategic collaboration advances the detailed study of early, individualized human responses to vaccinations as pharma companies race to deliver safe, effective vaccines sooner. physIQ, a pioneer in digital medicine, and CellCarta, a global leader in
Read More

AppliedVR Lands $29M for VR Platform to Treat Chronic Pain

by Fred Pennic 03/23/2021 Leave a Comment

AppliedVR Lands $29M for VR Platform to Treat Chronic Pain

What You Should Know: - AppliedVR, a Los Angeles, CA-based company advancing the next generation of digital medicine, today announced $29 million in Series A funding, bringing its total funds raised to date to $35 million. The round, which includes key investors F-Prime Capital, JAZZ Venture Partners, Sway Ventures, GSR Ventures, Magnetic Ventures and Cedars-Sinai, will fuel the company’s growth as it pursues full FDA approval over the next year. - Founded in 2015, AppliedVR provides
Read More

Executive Hires: Walgreens Appoints New CEO, Cityblock Health, Innovaccer, Others

by Jasmine Pennic 02/05/2021 Leave a Comment

Walgreens appoints Rosalind (Roz) Brewer as the company’s Chief Executive Officer, effective on March 15, 2021. Brewer will also join the WBA Board of Directors upon assuming the role. She succeeds Stefano Pessina who, as previously announced, will transition to the role of Executive Chairman of the Board of WBA. Brewer, 58, will become the first Black woman to lead a Fortune 500 company. Former Livongo President, Jennifer Schneider, has joined Cityblock Health’s Board of
Read More

Nuance Launches AI-Powered Patient Engagement Virtual Assistant Platform

by Fred Pennic 01/11/2021 Leave a Comment

Nuance Launches AI-Powered Patient Engagement Virtual Assistant Platform

What You Should Know: - Nuance Communications, Inc. launched an AI-powered patient engagement virtual assistant platform to transform omnichannel digital experiences for patients. - Healthcare provider organizations can now deploy a single, common cloud-based platform to support their entire patient journey across engagement channels using Nuance's market-leading Intelligent Engagement AI technology - The launch comes as patients increasingly expect the same level of engaging
Read More

FDA Grants AppliedVR Breakthrough Designation for Virtual Reality Chronic Pain Treatment

by Jasmine Pennic 10/21/2020 Leave a Comment

FDA Grants AppliedVR Breakthrough Designation for Virtual Reality Chronic Pain Treatment

What You Should Know: - FDA awards AppliedVR Breakthrough Device designation for treating treatment-resistant fibromyalgia and chronic intractable lower back pain - AppliedVR’s EaseVRx program helps patients learn self-management skills grounded in evidence-based cognitive-behavioral therapy (CBT) principles and other behavioral methods. AppliedVR, a pioneer advancing the next generation of digital medicine, today announced its EaseVRx product received Breakthrough Device designation
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

Q/A: Oatmeal Health Co-Founder Talks AI-Enabled Cancer Screening for the Underserved

GE HealthCare to Acquire Caption Health

GE HealthCare to Acquire Caption Health to Expand AI-Guided Ultrasounds

Epic, Impact Advisors, Nordic, Chartis Named 2023 Overall Best in KLAS® Awards

Epic, Impact Advisors, Nordic, Chartis Named 2023 Overall Best in KLAS® Awards

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |